L5 Capital Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-12 06:06 am Purchase | 2024-12-10 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 268,758 10.700% | 5,167 (+1.96%) | Filing |
| 2024-12-10 06:06 am Purchase | 2024-12-06 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 263,591 10.500% | 7,667 (+3.00%) | Filing |
| 2024-12-05 07:45 am Purchase | 2024-12-03 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 255,925 10.000% | 75,729 (+42.03%) | Filing |
| 2024-05-24 08:58 am Purchase | 2024-05-14 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 180,196 14.700% | 78,196 (+76.66%) | Filing |
| 2021-09-07 4:05 pm Unchanged | 2021-09-01 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 102,000 10.000% | 0 (Unchanged) | Filing |
| 2021-08-04 09:43 am Purchase | 2021-08-03 | 13G | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 102,000 10.000% | 53,667 (+111.03%) | Filing |
| 2021-06-28 4:15 pm Purchase | 2021-06-21 | 13G | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 48,333 5.010% | 48,333 (New Position) | Filing |